If you're interested in becoming an investigator, contact us for more information.
Spectrum conducts a range of clinical trials to bring new and novel products to the market. Please see the list below for a selected list of our trials of development drugs.
Please note, by selecting these links, you will be going to an external site that is not controlled by or affiliated with Spectrum Pharmaceuticals, Inc. These links are provided by Spectrum for informational purposes only. Spectrum accepts no responsibility for the content of any external sites.
Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After the Same-Day, Varying Dosing Time Schedules of Eflapegrastim Administration in Patients with Breast-Cancer Receiving Docetaxel and Cyclophosphamide
*Enrollment has been completed in the RECOVER and ADVANCE clinical studies.
Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Intravenous Doses of IGN002 Administered Weekly to Subjects with Refractory Non-Hodgkin Lymphoma (NHL)